| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 51, 672-673, Copyright © 1980 by Endocrine Society
ARTICLES |
RL Hintz and E Rinderknecht
Insulin-like growth factor I is a human plasma peptide with strong homology to human proinsulin. Many lines of evidence suggest that somatomedin-C and insulin-like growth factor I are identical molecules. However, no structural data regarding the carboxy-terminal end of somatomedin-C has yet been produced. We report a region-specific immunoassay directed against the carboxy-terminal end of insulin-like growth factor I. Somatomedin-C and insulin-like growth factor I are indistinguishable in this region-specific immunoassay. Insulin-like activity II and multiplication stimulating activity show partial cross reaction in this immunoassay. This study provides the first evidence about the carboxy-terminal portion of somatomedin-C and re-emphasizes that somatomedin-C and insulin-like growth factor I should be considered identical molecules.
This article has been cited by other articles:
![]() |
V. C. Russo, P. D. Gluckman, E. L. Feldman, and G. A. Werther The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain Endocr. Rev., December 1, 2005; 26(7): 916 - 943. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |